Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - Nasdaq - US03676C1009 - Common Stock - Currency: USD

29.52  -0.32 (-1.07%)

After market: 29.52 0 (0%)

Fundamental Rating

3

Overall ATEX gets a fundamental rating of 3 out of 10. We evaluated ATEX against 32 industry peers in the Diversified Telecommunication Services industry. While ATEX has a great health rating, there are worries on its profitability. ATEX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ATEX has reported negative net income.
ATEX had a positive operating cash flow in the past year.
In the past 5 years ATEX always reported negative net income.
In multiple years ATEX reported negative operating cash flow during the last 5 years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

ATEX has a worse Return On Assets (-11.78%) than 87.10% of its industry peers.
ATEX has a Return On Equity of -26.87%. This is in the lower half of the industry: ATEX underperforms 77.42% of its industry peers.
Industry RankSector Rank
ROA -11.78%
ROE -26.87%
ROIC N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K

More info and screens

7

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATEX has less shares outstanding than it did 1 year ago.
ATEX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ATEX has an Altman-Z score of -0.29. This is a bad value and indicates that ATEX is not financially healthy and even has some risk of bankruptcy.
ATEX's Altman-Z score of -0.29 is on the low side compared to the rest of the industry. ATEX is outperformed by 83.87% of its industry peers.
There is no outstanding debt for ATEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -0.29
ROIC/WACCN/A
WACC9.24%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 3.59 indicates that ATEX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.59, ATEX belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
A Quick Ratio of 3.59 indicates that ATEX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.59, ATEX belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 3.59
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

ATEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10200.00%.
ATEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 96.74%.
ATEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.40% yearly.
EPS 1Y (TTM)-10200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.56%
Revenue 1Y (TTM)96.74%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%47.43%

3.2 Future

Based on estimates for the next years, ATEX will show a very negative growth in Earnings Per Share. The EPS will decrease by -36.72% on average per year.
ATEX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.56% yearly.
EPS Next Y-220.46%
EPS Next 2Y13.35%
EPS Next 3Y-36.72%
EPS Next 5YN/A
Revenue Next Year40.43%
Revenue Next 2Y19.06%
Revenue Next 3Y30.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

ATEX's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ATEX is more expensive than 61.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.76
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

ATEX's earnings are expected to decrease with -36.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.35%
EPS Next 3Y-36.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIX INC

NASDAQ:ATEX (1/23/2025, 8:44:05 PM)

After market: 29.52 0 (0%)

29.52

-0.32 (-1.07%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners88.66%
Inst Owner Change0.08%
Ins Owners1.74%
Ins Owner Change1.42%
Market Cap549.66M
Analysts82.22
Price Target89.25 (202.34%)
Short Float %3.7%
Short Ratio6.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.83%
Min EPS beat(2)-83.01%
Max EPS beat(2)-14.66%
EPS beat(4)1
Avg EPS beat(4)-3.75%
Min EPS beat(4)-83.01%
Max EPS beat(4)103.16%
EPS beat(8)5
Avg EPS beat(8)47.27%
EPS beat(12)6
Avg EPS beat(12)2.29%
EPS beat(16)9
Avg EPS beat(16)2.39%
Revenue beat(2)0
Avg Revenue beat(2)-8.91%
Min Revenue beat(2)-12.96%
Max Revenue beat(2)-4.87%
Revenue beat(4)1
Avg Revenue beat(4)-7.17%
Min Revenue beat(4)-32.26%
Max Revenue beat(4)21.39%
Revenue beat(8)1
Avg Revenue beat(8)-21.1%
Revenue beat(12)2
Avg Revenue beat(12)-17.84%
Revenue beat(16)5
Avg Revenue beat(16)-7.83%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.6%
EPS NY rev (1m)0%
EPS NY rev (3m)0.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 98.03
P/FCF 32.76
P/OCF 15.81
P/B 3.95
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.02
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)0.9
FCFY3.05%
OCF(TTM)1.87
OCFY6.33%
SpS0.3
BVpS7.47
TBVpS-4.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.78%
ROE -26.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 299.29%
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 2520.03%
Cap/Sales 320.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.59
Quick Ratio 3.59
Altman-Z -0.29
F-Score5
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)1951.72%
Cap/Depr(5y)1293.44%
Cap/Sales(3y)1454.89%
Cap/Sales(5y)1277.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-155.56%
EPS Next Y-220.46%
EPS Next 2Y13.35%
EPS Next 3Y-36.72%
EPS Next 5YN/A
Revenue 1Y (TTM)96.74%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%47.43%
Revenue Next Year40.43%
Revenue Next 2Y19.06%
Revenue Next 3Y30.56%
Revenue Next 5YN/A
EBIT growth 1Y2.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-550.9%
EBIT Next 3Y-74.36%
EBIT Next 5YN/A
FCF growth 1Y210.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.08%
OCF growth 3YN/A
OCF growth 5YN/A